November 2025
The global lipid nanoparticles market size is evaluated at USD 1,142.30 million in 2025 and is expected to attain around USD 3,694.21 million by 2034, with a CAGR of 13.93%.
May 2026
The global hyperlipidemia drugs market size is calculated at USD 23.85 billion in 2025 and is projected to surpass USD 35.24 billion by 2035 with a CAGR of 3.98%.
November 2025
The global lecithin and phospholipids market size is estimated to hit around USD 11.92 billion by 2034 increasing from USD 6.76 billion in 2025, with a CAGR of 6.50%.
November 2025
The global pharmaceutical lipid-based excipients market size accounted for USD 2.02 billion in 2025 and is predicted to hit around USD 3.17 billion by 2034, growing at a CAGR of 5.13%.
July 2025
The global lipid-lowering drugs market size was evaluated at USD 34.27 billion in 2024 and is projected to attain around USD 48.11 billion by 2034 with a CAGR of 3.45%.
July 2025
The global point of care lipid test market size was valued at USD 307.71 million in 2024 and is predicted to attain around USD 472.54 million by 2034 with a CAGR of 4.38%.
September 2025
The global LNP CDMO market size was evaluated at USD 205.47 million in 2024 and is predicted to hit around USD 820.46 million by 2034, growing at a CAGR of 14.85%.